%0 Journal Article %A Kathryn G. Dewey %A Christine P. Stewart %A K. Ryan Wessells %A Elizabeth L. Prado %A Charles D. Arnold %T Small-quantity lipid-based nutrient supplements for prevention of child malnutrition and promotion of healthy development: Overview of individual participant data meta-analysis and programmatic implications %D 2021 %R 10.1101/2021.02.15.21251449 %J medRxiv %P 2021.02.15.21251449 %X Small-quantity lipid-based nutrient supplements (SQ-LNS) were designed to provide multiple micronutrients within a food base that also provides energy, protein and essential fatty acids, and were targeted towards the prevention of malnutrition in low- and middle-income countries. Previous meta-analyses have demonstrated beneficial effects of SQ-LNS on child growth, anemia and mortality. To further examine efficacy and effectiveness of SQ-LNS, and explore study-level and individual-level modifiers of the effects, we conducted an individual participant data (IPD) meta-analysis of 14 randomized controlled trials of SQ-LNS provided to infants and young children 6 to 24 mo of age (n > 37,000). We examined growth, development, anemia and micronutrient status outcomes. Children who received SQ-LNS had a 12-14% lower prevalence of stunting, wasting and underweight, were 16-19% less likely to score in the lowest decile for language, social-emotional, and motor development, and had a 16% lower prevalence of anemia and 64% lower prevalence of iron-deficiency anemia, compared to control group children. For most outcomes, beneficial effects of SQ-LNS were evident regardless of study-level characteristics including region, stunting burden, malaria prevalence, sanitation, water quality, duration of supplementation, frequency of contact or average reported compliance with SQ-LNS. For certain outcomes, targeting based on population-level socioeconomic status or undernutrition may be worthwhile, as the benefits of SQ-LNS for iron status, anemia and child development were larger in sub-groups with a greater potential to benefit. A greater impact of SQ-LNS might be possible by co-packaging it with interventions that reduce constraints on response, such as prevention and control of pre-and postnatal infections, improving maternal nutrition, improving health care access, and promotion of early child development. Policy-makers and program planners should consider including SQ-LNS in strategies to reduce child mortality, stunting, wasting, anemia, iron deficiency and developmental impairments. This study was registered at www.crd.york.ac.uk/PROSPERO as CRD42019146592, CRD42020159971 and CRD42020156663.Competing Interest StatementAll authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: KGD, KRW and CDA had financial support from the Bill & Melinda Gates Foundation for the submitted work; KRW has received research grants from Nutriset, SAS, outside the submitted work; all other co-authors report financial support for the original trials that contributed data to this paper, but not for the work directly related to this analysis; no other relationships or activities that could appear to have influenced the submitted work.Clinical Protocols https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42019146592 https://osf.io/ymsfu/ https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020159971 https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020156663 Funding StatementSupported by Bill & Melinda Gates Foundation grant OPP49817 (to KGD).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The analyses were approved by the institutional review board of the University of California, Davis (1463609-1). All individual trial protocols were approved by their relevant institutional ethics committees.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData described in the manuscript, code book, and analytic code will not be made available because they are compiled from 14 different trials, and access is under the control of the investigators of each of those trials.AGPα-1-acid glycoproteinBMIbody-mass indexCRPC-reactive proteinHbhemoglobinHCZhead circumference z-scoreiLiNSInternational Lipid-based Nutrient Supplements ProjectIPDindividual participant dataIYCFinfant and young child feedingLAZlength-for-age z-scoreLNSlipid-based nutrient supplementMNPmultiple micronutrient powderMUACmid-upper arm circumferenceMUACZmid-upper arm circumference z-scoreRBPretinol binding proteinRDNSRang-Din Nutrition StudyRUTFready-to-use therapeutic foodSBCCsocial and behavior change communicationSESsocio-economic statusSQ-LNSsmall-quantity lipid-based nutrient supplementsWASHwater sanitation and hygieneWAZweight-for-age z-scoreWLZweight-for-length z-score %U https://www.medrxiv.org/content/medrxiv/early/2021/02/18/2021.02.15.21251449.full.pdf